FILINGS
| ALNY 0001178670 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2023-03-01 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-03-01 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-03-01 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-27 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-27 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-27 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-27 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-27 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-23 | S-8 | S-8 | View Document |
| 2023-02-23 | 10-K | 10-K | View Document |
| 2023-02-23 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2023-02-14 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-14 | CT ORDER | View Document | |
| 2023-02-14 | SC 13G/A | View Document | |
| 2023-02-13 | SC 13G/A | SEC SCHEDULE 13G | View Document |
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | View Document |
| 2023-02-09 | SC 13G/A | View Document | |
| 2023-02-06 | SC 13G/A | SEC SCHEDULE 13G | View Document |
| 2023-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-01-31 | SC 13G/A | View Document | |
| 2023-01-19 | SC 13G/A | View Document | |
| 2023-01-09 | 4 | PRIMARY DOCUMENT | View Document |
| 2023-01-09 | 3 | PRIMARY DOCUMENT | View Document |
| 2023-01-09 | 8-K | FORM 8-K | View Document |
| 2023-01-06 | 8-K | 8-K | View Document |
| 2022-12-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-11-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-10-27 | 10-Q | 10-Q | View Document |
| 2022-10-27 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2022-09-16 | 8-K | 8-K | View Document |
| 2022-09-13 | 8-K | 8-K | View Document |
| 2022-09-09 | SC 13G | SEC SCHEDULE 13G | View Document |
| 2022-08-24 | 8-K | 8-K | View Document |
| 2022-08-24 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-08-24 | 3 | PRIMARY DOCUMENT | View Document |
| 2022-08-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-08-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-08-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-08-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-08-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-08-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-07-28 | 10-Q | 10-Q | View Document |
| 2022-07-28 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2022-07-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-06-14 | 8-K | 8-K | View Document |
| 2022-05-23 | 8-K | 8-K | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-04-28 | 10-Q | 10-Q | View Document |
| 2022-04-28 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2022-04-05 | DEFA14A | DEFA14A | View Document |
| 2022-04-05 | DEF 14A | DEF 14A | View Document |
| 2022-04-05 | 8-K | 8-K | View Document |
| 2022-04-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-04-04 | 8-K | 8-K | View Document |
| 2022-03-17 | 8-K | 8-K | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-14 | SC 13G | View Document | |
| 2022-02-11 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-10 | 10-K | 10-K | View Document |
| 2022-02-10 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2022-02-09 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-09 | 3 | PRIMARY DOCUMENT | View Document |
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | View Document |
| 2022-02-09 | SC 13G/A | View Document | |
| 2022-02-04 | SC 13G/A | SEC SCHEDULE 13G | View Document |
| 2022-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-02-03 | SC 13G/A | View Document | |
| 2022-01-18 | SC 13G/A | View Document | |
| 2022-01-10 | 8-K | 8-K | View Document |
| 2022-01-04 | 8-K | 8-K | View Document |
| 2022-01-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-01-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2022-01-04 | 3 | PRIMARY DOCUMENT | View Document |
| 2021-12-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-12-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-12-23 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-12-20 | 8-K | 8-K | View Document |
| 2021-12-14 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-11-12 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-10-29 | 4 | PRIMARY DOCUMENT | View Document |
| 2021-10-28 | 10-Q | 10-Q | View Document |
| 2021-10-28 | 8-K | 8-K | View Document |
| 2021-09-08 | 8-K | 8-K | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
